STC2 and neoplasm: Furthermore, the loss of STC2 suppressed E2-stimulated tumor growth in vivo, suggesting that STC2 deficiency inhibits E2-stimulated proliferation and tumor growth by activating phosphorylated-AMP–activated protein kinase (AMPK) signaling, particularly in type I EnCa (84).